Apex Capital Completes ₹71 Cr Warrant Conversion, Boosts Capital

BANKINGFINANCE
Whalesbook Corporate News Logo
AuthorVihaan Mehta|Published at:
Apex Capital Completes ₹71 Cr Warrant Conversion, Boosts Capital
Overview

Apex Capital and Finance Ltd has finalized the conversion of 76 lakh warrants into equity shares, raising ₹71.25 crore. This capital infusion significantly boosts the company's paid-up equity share capital from ₹5.92 crore to ₹13.52 crore, strengthening the NBFC's financial base for future lending.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Apex Capital Boosts Finances with ₹71 Cr Warrant Conversion

Apex Capital and Finance Ltd has successfully converted 76 lakh warrants into equity shares, injecting ₹71.25 crore into the company. This significant capital infusion has more than doubled the firm's paid-up equity share capital, raising it from ₹5.92 crore to ₹13.52 crore. The move is set to bolster the non-banking financial company's (NBFC) financial foundation for upcoming lending activities.

The Warrant Conversion Explained

Apex Capital and Finance Ltd announced the successful conversion of all its outstanding 76,00,000 warrants into fully paid-up equity shares. The company received ₹71.25 crore against these warrants.

Following this allotment, the company's paid-up equity share capital has substantially increased. It rose from ₹591.99 lakh (₹5.92 crore) prior to the allotment to ₹1351.99 lakh (₹13.52 crore) afterwards.

All previously issued warrants are now fully converted. The newly issued shares rank equally with existing equity shares, and the company reported no change in control as a result of this conversion.

Why This Matters for Apex Capital

For a non-banking financial company (NBFC) like Apex Capital, access to fresh capital is crucial for growth. This ₹71.25 crore infusion strengthens its balance sheet significantly.

The capital raise allows Apex Capital to enhance its lending capacity, improve its Capital Adequacy Ratio (CAR), and potentially pursue larger financing opportunities. This move signals management's proactive strategy to build a stronger financial base for expansion and operational resilience.

Strategic Capital Raises

Apex Capital and Finance has a history of strategically raising capital to fuel its expansion. The company previously conducted a Qualified Institutional Placement (QIP) in FY23. That QIP aimed at enhancing its capital base and enabling the expansion of its lending portfolio. The current warrant conversion represents a continuation of this capital-strengthening strategy.

What Changes Now

  • Increased Equity Base: The total number of outstanding equity shares has risen, reinforcing the company's equity structure.
  • Enhanced Lending Capacity: With additional capital, Apex Capital is better positioned to expand its loan book and financial services.
  • Improved Financial Ratios: The capital infusion is expected to positively impact key financial metrics, including its Capital Adequacy Ratio (CAR).
  • Shareholder Dilution: Existing shareholders will experience a dilution in their percentage ownership due to the issuance of new shares.
  • Listing of New Shares: The 76,00,000 newly allotted equity shares are expected to be listed on the BSE, increasing the total traded float.

Risks to Watch

The company's filing did not mention specific risks directly associated with this warrant conversion. However, NBFCs generally face risks such as potential changes in regulations, credit risk within their loan portfolios, and sensitivity to interest rate fluctuations.

Peer Comparison

While Apex Capital operates as a smaller entity in the NBFC sector, other listed companies like Satin Creditcare Network Ltd and Aptus Value Housing Finance India Ltd also periodically raise capital to support their growth. For instance, Satin Creditcare has utilized preferential allotments to strengthen its finances. Such capital-raising efforts are common in the sector as firms aim to scale operations and meet increasing credit demand.

What to Track Next

Investors and analysts will be watching several key developments:

  • BSE Listing Approval: The official listing of the 76,00,000 new equity shares on the BSE.
  • Capital Deployment: How Apex Capital plans to utilize the newly raised ₹71.25 crore to drive business growth and expand its lending activities.
  • Financial Performance: Monitoring future quarterly results to assess the impact of the increased capital on profitability and asset growth.
  • Shareholder Structure: Observing any shifts in promoter or public shareholding patterns following the share listing.
  • Regulatory Compliance: Ensuring continued adherence to NBFC norms and capital adequacy requirements.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.